# A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)

> **NCT01613586** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 287 (actual)

## Conditions studied

- Cystitis, Interstitial
- Urinary Bladder Disease
- Pain
- Urologic Diseases

## Interventions

- **DRUG:** ASP3652
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01613586
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-31
- **Primary completion:** 2014-03-18
- **Final completion:** 2014-03-18
- **Target enrollment:** 287 (ACTUAL)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613586, "A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01613586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*